000 01068 a2200301 4500
005 20250513053717.0
264 0 _c19950105
008 199501s 0 0 eng d
022 _a0271-8235
024 7 _a10.1055/s-2008-1041067
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSanders, D B
245 0 0 _aLambert-Eaton myasthenic syndrome: pathogenesis and treatment.
_h[electronic resource]
260 _bSeminars in neurology
_cJun 1994
300 _a111-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCalcium Channels
_ximmunology
650 0 4 _aCombined Modality Therapy
650 0 4 _aElectromyography
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aIon Channel Gating
_ximmunology
650 0 4 _aLambert-Eaton Myasthenic Syndrome
_xepidemiology
650 0 4 _aLung Neoplasms
_xcomplications
650 0 4 _aPresynaptic Terminals
_ximmunology
773 0 _tSeminars in neurology
_gvol. 14
_gno. 2
_gp. 111-7
856 4 0 _uhttps://doi.org/10.1055/s-2008-1041067
_zAvailable from publisher's website
999 _c7984152
_d7984152